Krämer, Günter
Article History
Accepted: 23 November 2022
First Online: 8 December 2022
Declarations
:
: G. Krämer received honoraria for consulting and lectures from Arvelle Therapeutics International/Angelini Pharma Group, GW Pharmaceuticals/Jazz Pharma, OM Pharma Suisse, Precisis, and Sandoz between 2018 and 2022. He is or was a member of the “Management of First Epileptic Seizure and Epilepsies” guideline group of the German Neurological Society and the ILAE Task Force on Epilepsy in the Elderly (2017–2021).
: No studies on humans or animals were conducted by the author for this article. For the studies listed, the ethical guidelines stated therein apply in each case.
: The supplement containing this article is not sponsored by industry.
Free to read: This content has been made available to all.